These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 18813843)
1. Identification of tumor-associated antigens in human hepatocellular carcinoma by autoantibodies. Chen X; Fu S; Chen F; Chen H; Chen Z Oncol Rep; 2008 Oct; 20(4):979-85. PubMed ID: 18813843 [TBL] [Abstract][Full Text] [Related]
2. Identification of the antigens predominantly reacted with serum from patients with hepatocellular carcinoma. Uemura M; Nouso K; Kobayashi Y; Tanaka H; Nakamura S; Higashi T; Ono T; Nakayama E; Hanafusa T; Shiratori Y Cancer; 2003 May; 97(10):2474-9. PubMed ID: 12733146 [TBL] [Abstract][Full Text] [Related]
3. Definition of tumor-associated antigens in hepatocellular carcinoma. Stenner-Liewen F; Luo G; Sahin U; Tureci O; Koslovski M; Kautz I; Liewen H; Pfreundschuh M Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):285-90. PubMed ID: 10750667 [TBL] [Abstract][Full Text] [Related]
4. Identification of HCC-22-5 tumor-associated antigen and antibody response in patients. Zhou SF; Xie XX; Bin YH; Lan L; Chen F; Luo GR Clin Chim Acta; 2006 Apr; 366(1-2):274-80. PubMed ID: 16356486 [TBL] [Abstract][Full Text] [Related]
5. Identification of tumor-associated antigens by using SEREX in hepatocellular carcinoma. Wang K; Xu X; Nie Y; Dai L; Wang P; Zhang J Cancer Lett; 2009 Aug; 281(2):144-50. PubMed ID: 19304375 [TBL] [Abstract][Full Text] [Related]
6. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma. Gehring AJ; Ho ZZ; Tan AT; Aung MO; Lee KH; Tan KC; Lim SG; Bertoletti A Gastroenterology; 2009 Aug; 137(2):682-90. PubMed ID: 19394336 [TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma. Takashima M; Kuramitsu Y; Yokoyama Y; Iizuka N; Harada T; Fujimoto M; Sakaida I; Okita K; Oka M; Nakamura K Proteomics; 2006 Jul; 6(13):3894-900. PubMed ID: 16767786 [TBL] [Abstract][Full Text] [Related]
8. Screening of autoantibodies as potential biomarkers for hepatocellular carcinoma by using T7 phase display system. Liu H; Zhang J; Wang S; Pang Z; Wang Z; Zhou W; Wu M Cancer Epidemiol; 2012 Feb; 36(1):82-8. PubMed ID: 22018955 [TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to survivin in patients with chronic hepatitis and hepatocellular carcinoma. Yagihashi A; Asanuma K; Kobayashi D; Tsuji N; Torigoe T; Sato N; Watanabe N Autoimmunity; 2005 Sep; 38(6):445-8. PubMed ID: 16278150 [TBL] [Abstract][Full Text] [Related]
10. [Screening hepatocellular carcinoma autoantibodies by serological proteome analysis]. Feng JT; Liu YK; Dai Z; Zhou HJ; Song HY; Qin LX; Jin H; Lu HJ; Tang ZY Zhonghua Gan Zang Bing Za Zhi; 2005 Nov; 13(11):832-5. PubMed ID: 16313728 [TBL] [Abstract][Full Text] [Related]
11. Multiple variants and a differential splicing pattern of kinectin in human hepatocellular carcinoma. Wang HC; Su YR; Han KJ; Pang XW; Peng JR; Liang B; Wang S; Chen WF Biochem Cell Biol; 2004 Apr; 82(2):321-7. PubMed ID: 15060627 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma. Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803 [TBL] [Abstract][Full Text] [Related]
13. Serological identification of tumor antigens of esophageal squamous cell carcinoma. Shimada H; Nakashima K; Ochiai T; Nabeya Y; Takiguchi M; Nomura F; Hiwasa T Int J Oncol; 2005 Jan; 26(1):77-86. PubMed ID: 15586227 [TBL] [Abstract][Full Text] [Related]
14. [Diagnosis of hepatocellular carcinoma using chicken anti-monoclonal antibody--as tumor marker on the heterophilic hanganutziu-deicher antigen]. Koda T; Shimosakoda T; Nishinaka S; Asaoka H; Nakaba H; Tamura I; Matsuda H Gan To Kagaku Ryoho; 1994 Dec; 21(16):2771-7. PubMed ID: 7993113 [TBL] [Abstract][Full Text] [Related]
15. Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma. Himoto T; Kuriyama S; Zhang JY; Chan EK; Kimura Y; Masaki T; Uchida N; Nishioka M; Tan EM Int J Oncol; 2005 Oct; 27(4):1079-85. PubMed ID: 16142326 [TBL] [Abstract][Full Text] [Related]
16. Significance of autoantibodies against insulin-like growth factor II mRNA-binding proteins in patients with hepatocellular carcinoma. Himoto T; Kuriyama S; Zhang JY; Chan EK; Nishioka M; Tan EM Int J Oncol; 2005 Feb; 26(2):311-7. PubMed ID: 15645114 [TBL] [Abstract][Full Text] [Related]
17. Significant increase in the antibody to Gal alpha 1-3Gal structure in sera of patients with hepatocellular carcinoma after transcatheter arterial embolization. Kashiwagi M; Ikeda Y; Iwamori M; Toda G; Nagai Y Cancer Res; 1989 Aug; 49(16):4396-401. PubMed ID: 2545342 [TBL] [Abstract][Full Text] [Related]
18. [Expression of NY-ESO-1/LAGE-1 genes in hepatocellular carcinoma and autologous humoral responses induced thereby]. Xing BC; Yuan YH; Hu ZG; Liu YX; Han Y; Liu N; Chen WF; Wang Y Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1980-2. PubMed ID: 15730810 [TBL] [Abstract][Full Text] [Related]
19. Increased immunostimulatory activity conferred to antigen-presenting cells by exposure to antigen extract from hepatocellular carcinoma after radiofrequency thermal ablation. Zerbini A; Pilli M; Fagnoni F; Pelosi G; Pizzi MG; Schivazappa S; Laccabue D; Cavallo C; Schianchi C; Ferrari C; Missale G J Immunother; 2008 Apr; 31(3):271-82. PubMed ID: 18317360 [TBL] [Abstract][Full Text] [Related]
20. [Screening and analysis of genes encoding hepatocellular carcinoma associated tumor antigens]. Wang HC; Yang MH; Shi YY; Pang XW; Yang XA; Peng JR; Leng XS; Chen WF Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):343-6. PubMed ID: 15918967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]